Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2021
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2021.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not list specific figures within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text; contained in the referenced press release.
- Debt and Liquidity: Not provided in this text; contained in the referenced press release.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus prior periods. It only confirms the issuance of results for the periods ended June 30, 2021.
Guidance, Outlook, and Management Commentary
Management Action: The Company issued a press release on August 5, 2021, and scheduled a conference call for 8:00 AM ET on the same date to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and six months ended June 30, 2021.
- Verify the details of the conference call held on August 5, 2021, for management commentary on the results.
- Confirm whether the press release includes updated guidance or outlook for the fiscal year.
- Note that the data in this 8-K is not legally "filed" for liability purposes under Section 18 of the Exchange Act.